← All Sponsors
SPONSOR

Taizhou Mabtech Pharmaceutical Co.,Ltd

Total Trials
1
Recruiting
1
Phases
Phase 4
Conditions studied: Crohn Disease
NCT05906576 Phase 4
Recruiting

Post-marketing Registry Study of Infliximab for Injection in Chinese Pediatric Crohn's Disease Patients

Crohn Disease
China View Trial →